Form 8-K - Current report:
SEC Accession No. 0001437749-21-028983
Filing Date
2021-12-20
Accepted
2021-12-20 17:11:55
Documents
15
Period of Report
2021-12-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20211220_8k.htm   iXBRL 8-K 26099
2 EXHIBIT 99.1 ex_318151.htm EX-99.1 14028
7 logo.jpg GRAPHIC 6854
  Complete submission text file 0001437749-21-028983.txt   186830

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA stab-20211220.xsd EX-101.SCH 3594
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20211220_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20211220_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20211220_pre.xml EX-101.PRE 11585
9 EXTRACTED XBRL INSTANCE DOCUMENT cbli20211220_8k_htm.xml XML 2569
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

EIN.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 211506020
SIC: 2834 Pharmaceutical Preparations